The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.
Shivani Sampathkumar, BS
Advertisement
Articles by Shivani Sampathkumar, BS
Advertisement
Latest Updated Articles
- Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?
February 14th 2018
Advertisement
Advertisement
Trending on AJMC
1
FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week
2
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
3
Eplontersen Misses Primary End Point in Phase 3 ATTR-CM Cardiovascular Outcomes Trial
4
Impact of Automated Insulin Delivery on Type 2 Diabetes Measures
5